Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.19.3.a.u2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Common stock
Class C Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Class A Common Stock
Class B Common Stock
Class C Common Stock
Total
Balance at Dec. 29, 2016 $ 77   $ 6 $ 117,270 $ 176 $ 16,754       $ 134,283
Beginning balance (in shares) at Dec. 29, 2016 76,847,000 396,000 6,275,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense       4,951   8       4,959
Conversion of Class B Common Stock (in shares) 396,000 (396,000)                
Conversion of Class C Common Stock $ 6   $ (6)              
Conversion of Class C Common Stock (in shares) 6,275,000   (6,275,000)              
Exercise of stock options $ 2     8,872           $ 8,874
Exercise of stock options (in shares) 1,828,000                 1,828,339
IPO proceeds $ 10     192,326           $ 192,336
Number of shares issued 10,147,000                  
Issuance of restricted stock award (in shares) 15,000                  
Other comprehensive gain (loss), net of tax, pre-adoption         (381)         (381)
Net income           102,788       102,788
Balance at Dec. 28, 2017 $ 96     323,419 (205) 119,550       442,860
Ending balance (in shares) at Dec. 28, 2017 95,509,000                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cumulative effect from adoption           7,826       7,826
Stock-based compensation expense       6,514           6,514
Exercise of stock options $ 2     10,529           $ 10,531
Exercise of stock options (in shares) 2,069,000                 2,069,195
Issuance of restricted stock award (in shares) 10,000                  
Other comprehensive gain (loss), net of tax, pre-adoption         391         $ 391
Net income           116,187       116,187
Balance at Dec. 27, 2018 $ 98     340,462 186 243,563       584,309
Ending balance (in shares) at Dec. 27, 2018 97,588,000           97,588,539 0 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cumulative effect from adoption           (179)       (179)
Stock-based compensation expense       8,711           8,711
Exercise of stock options $ 3     18,795           $ 18,798
Exercise of stock options (in shares) 3,741,000                 3,740,749
Shares issued under employee stock plan       2,445           $ 2,445
Shares issued under employee stock plan (in shares) 105,000                 104,363
Issuance of restricted stock award (in shares) 24,000                  
Other comprehensive gain (loss), net of tax, post-adoption         (379)         $ (379)
Net income           150,631       150,631
Balance at Dec. 26, 2019 $ 101     $ 370,413 $ (193) $ 394,015       $ 764,336
Ending balance (in shares) at Dec. 26, 2019 101,458,000           101,457,858 0 0